The direct effects of neurotrophins on amygdala hyperactivity in MDD are currently under investigation; nevertheless, alterations in BDNF signaling within the amygdala may modify its excitability and lead to heightened negative affect and anxiety symptoms [48]. This evidence concerns the gene BDNF and Anxiety.